Edwards Lifesciences (EW) Enterprise Value (2009 - 2026)

Edwards Lifesciences' Enterprise Value history runs 18 years deep, the most recent figure standing at -$3.7 billion for Q1 2026.

• On a quarterly basis, Enterprise Value rose 4.28% year-over-year to -$3.7 billion in Q1 2026; TTM through Mar 2026 was -$3.7 billion, a 4.28% increase from a year earlier, with the FY2025 full-year figure at -$4.2 billion, down 8.05% from the prior year.
• Enterprise Value climbed to -$3.7 billion in Q1 2026 per EW's latest filing, from -$4.2 billion in the prior quarter.
• Across five years, Enterprise Value topped out at -$442.8 million in Q4 2023 and bottomed at -$4.4 billion in Q3 2024.
• The 5-year median for Enterprise Value is -$1.8 billion (2023), against an average of -$2.5 billion.
• Across the five-year window, Enterprise Value soared 63.34% in 2023 and sank 783.33% in 2024, its largest moves.
• Year by year, Enterprise Value stood at -$1.2 billion in 2022, then soared by 63.34% to -$442.8 million in 2023, then plunged by 783.33% to -$3.9 billion in 2024, then decreased by 8.05% to -$4.2 billion in 2025, then gained by 13.13% to -$3.7 billion in 2026.
• Per Business Quant, the three latest EW Enterprise Value figures stand at -$3.7 billion (Q1 2026), -$4.2 billion (Q4 2025), and -$3.8 billion (Q3 2025).